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Introduction
In Saccharomyces cerevisiae, the conserved phosphatase Cdc14 
regulates late mitotic events (Stegmeier and Amon, 2004) by 
antagonizing Cdk function to allow exit from mitosis. At ana-
phase onset, Cdc14 is released from the nucleolus into the   
nucleoplasm and cytoplasm, and becomes involved in sharpen-
ing of the metaphase to anaphase transition, spindle stabiliza-
tion, chromosomal passenger protein redistribution, segregation 
of ribosomal DNA, and triggering of mitotic exit (Stegmeier 
and Amon, 2004; Queralt and Uhlmann, 2008).
Vertebrates possess two isoforms of Cdc14, named Cdc14A 
and  Cdc14B;  in  hominoids,  a  gene  retro-duplication  event   
gave rise to an additional Cdc14 family member, Cdc14Bretro,   
whose expression is brain and testis specific (Rosso et al., 
2008). Cdc14A localizes at the centrosome in interphase human 
cells. Its overexpression caused premature centrosome splitting, 
whereas its depletion induced impaired centrosome separa-
tion and failure of cytokinesis (Kaiser et al., 2002; Mailand 
et al., 2002). Based on RNAi depletion and overexpression 
experiments, nucleolar human Cdc14B (hCdc14B) has been 
implicated in mitotic spindle assembly, centriole duplication,   
and mitotic exit (Kaiser et al., 2002; Mailand et al., 2002; 
Dryden et al., 2003; Cho et al., 2005; Wu et al., 2008). Recently, 
Bassermann et al. (2008) suggested that hCdc14B has a cen-
tral role in the G2 DNA damage checkpoint through regulation 
of the activity of the anaphase-promoting complex/cyclosome 
(APC/C) subunit Cdh1.
To obtain a clearer picture of the functions of vertebrate 
Cdc14 genes, we analyzed avian and human cell lines in which 
Cdc14A and Cdc14B genes were deleted by gene targeting. We 
demonstrate that neither Cdc14A nor Cdc14B is essential for a 
functional G2 DNA damage checkpoint in response to double-
strand breaks (DSBs). Instead, cells lacking either phosphatase 
show elevated levels of spontaneous DNA damage and impaired 
repair, uncovering a novel role for Cdc14A and Cdc14B.
A 
recent study suggested that human Cdc14B phos-
phatase has a central function in the G2 DNA 
damage checkpoint. In this study, we show that 
chicken DT40, human HCT116, and human telomerase 
reverse  transcription–immortalized  retinal  pigment  epi-
thelial cells deleted for the Cdc14A or Cdc14B gene are 
DNA damage checkpoint proficient and arrest efficiently 
in G2 in response to irradiation. Cdc14A knockout (KO) 
or Cdc14B-KO cells also maintain normal levels of Chk1 
and Chk2 activation after irradiation. Surprisingly, how-
ever, irradiation-induced -H2A.X foci and DNA double-
strand breaks persist longer in Cdc14A-KO or Cdc14B-KO 
cells than controls, suggesting that Cdc14 phosphatases 
are required for efficient DNA repair.
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activation. The role of Cdc14A in the G2 DNA damage check-
point was not investigated (Bassermann et al., 2008).
In agreement with the data of Bassermann et al. (2008), 
DT40 cells expressing cCdc14B-GFP after synchronization in G2 
and  exposure  to    irradiation  (IR)  showed  a  relocalization  of 
cCdc14B from the nucleolus to the nucleus (Fig. S3, A and B), 
whereas cCdc14A remained at the centrosome (Fig. S3, C and D).
Using cCdc14A-KO and cCdc14B-KO DT40 cell lines, we 
assayed for a defect in the G2 DNA damage checkpoint. As a 
control for checkpoint deficiency, we used DT40 Chk1-KO cells 
(Zachos et al., 2003). To quantify G2 checkpoint proficiency, we 
first added nocodazole (Noco) to the growth medium to trap cells 
in mitosis. This allowed us to measure the number of cells that 
entered M phase from G2 by staining for histone 3 phosphory-
lated on Ser10 (pH3). WT, cCdc14A-KO, cCdc14B-KO, and 
Chk1-KO  DT40  cells  were  incubated  in  medium  containing 
Noco for 8 h with or without prior exposure to IR. Chk1-KO cells 
accumulate in mitosis to a similar extent regardless of prior IR 
(Zachos et al., 2003). In marked contrast, IR strongly reduced 
mitotic accumulation in DT40 WT, cCdc14A-KO, and cCdc14B-
KO cells, which is indicative of a functional G2 checkpoint 
(Fig. 1 A, green bars). Similar results were obtained when cells 
were pulsed for 1 h with the DNA-damaging drug doxorubicin 
(DXR; unpublished data).
G2 phase–specific activation of APC/C
Cdh1 after DNA dam-
age was previously reported in DT40 cells (Sudo et al., 2001).   
To evaluate the importance of Cdh1 for DNA damage–induced 
cell cycle arrest in G2 in DT40 cells, Cdh1-KO DT40 cells were 
treated as in Fig. 1 A, and the percentage of mitotic cells (MI) 
was determined by flow cytometry. Cdh1-KO cells were arrested 
after IR as efficiently as WT cells (Fig. 1 A, green bars).
The nature of the G2 arrest after DNA damage varies ac-
cording to the position of a cell in the cell cycle at the time when 
damage occurs (Xu et al., 2002). Involvement of hCdc14B and 
APC/C
Cdh1 in the G2 checkpoint has been suggested specifi-
cally for human cells exposed to damage in G2 (Bassermann 
et al., 2008). To address the possibility that the discrepancies be-
tween the phenotype described by Bassermann et al. (2008) after 
hCdc14B knockdown and our observations in DT40 cCdc14B-KO 
cells were a result of irradiating populations of asynchronously 
growing cells, WT, cCdc14A-KO, cCdc14B-KO, Chk1-KO, 
and Cdh1-KO DT40 cells were synchronized in early S phase 
with aphidicolin, released for 4 h to allow progression into G2   
(Fig. 1 B), and exposed to IR. Under these conditions, cCdc14A-
KO, cCdc14B-KO, and Cdh1-KO cells maintained their ability to 
arrest in G2 after damage as efficiently as WT cells, as shown by 
the reduction in their MI (Fig. 1 C). To exclude the possibility that 
the G2 checkpoint proficiency in cCdc14-KO cells was caused 
by adaptation, we treated transgenic cCdc14A-KO/cCdc14A-HA 
and cCdc14B-KO/cCdc14B-HA cells with 4-hydroxytamoxifen 
to activate Cre recombinase and remove the cDNAs encoding 
cCdc14A-HA or cCdc14B-HA (Fig. S3 E). When G2 checkpoint 
proficiency was assessed immediately after transgene removal, 
cells arrested efficiently after IR (Fig. S3 F).
Prolonged G2 arrest after DNA damage induces centro-
some amplification in human and DT40 cells, and this amplifi-
cation  is  dependent  on  Chk1  activity  (Dodson  et  al.,  2004; 
Results and discussion
Cdc14A- and Cdc14B-deficient DT40  
cell lines
Chicken DT40 B-lymphoma cells show high efficiency of tar-
geted integration of transfected constructs, allowing the disrup-
tion of genes through homologous recombination (Buerstedde 
and Takeda, 1991). Therefore, we analyzed the function of Cdc14A 
and Cdc14B in this cell line.
Computational (GNOMON) analysis of the chicken genome 
predicts orthologues of Cdc14A (chicken Cdc14A [cCdc14A]; 
GenBank accession no. NC_006095.2) and Cdc14B (cCdc14B; 
NCBI Protein database accession no. XP_425045.2) on chro-
mosomes 8 and Z, respectively. However, only parts of these 
sequences are similar to human and mouse Cdc14 proteins. 
Therefore, we isolated cCdc14A and cCdc14B cDNAs by RT-PCR 
from total RNA of DT40 wild-type (WT) cells (unpublished 
data). These cDNA sequences predict cCdc14A and cCdc14B 
proteins conserved with other species throughout their length 
(GU550056 and GU550055). The chicken genome does not 
possess a Cdc14Bretro gene (Rosso et al., 2008).
cCdc14A was detected at the centrosome of cells in inter-
phase and late mitosis (Fig. S1 A). This localization is consistent 
with that of hCdc14A (Kaiser et al., 2002; Mailand et al., 2002). 
We were unable to raise antibodies against cCdc14B protein 
(unpublished data). Therefore, we generated a DT40 cell line sta-
bly expressing cCdc14B-GFP. In agreement with the localization 
of hCdc14B (Kaiser et al., 2002; Mailand et al., 2002), cCdc14B-
GFP localized to the nucleus in interphase cells with an enrich-
ment in the nucleolus (Fig. S1 B). In mitosis, cCdc14B-GFP was 
dispersed throughout the cell (unpublished data).
Next, we generated cCdc14A knockout (KO) and cCdc14B-
KO cell lines (Fig. S1, C–G; and Fig. S2, A–C). Surpris-
ingly, cells lacking either cCdc14A or cCdc14B were viable. 
Moreover,  the  doubling  time  of  the  cCdc14B-KO  cell  lines 
was indistinguishable from that of WT cells (Fig. S2 D). This 
indicates that cCdc14B is not essential for viability and pro-
liferation of DT40 cells. hCdc14B has been proposed to reg-
ulate  mitotic  exit  by  interacting  with  SIRT2  (Dryden  et  al., 
2003). However, the mitotic index (MI) of cCdc14B-KO cells 
did not show any significant increase indicative of defects in   
mitotic exit (Fig. S2 E). This is consistent with the lack of a 
mitotic exit defect of hCdc14B
/ cells (Berdougo et al., 2008).
In cCdc14B-KO cells, the levels of the cCdc14A protein 
were not increased compared with WT cells, and cCdc14A was 
still associated with the centrosome (Fig. S2, F and G). Thus, it 
is  unlikely  that  up-regulation  or  relocalization  of  cCdc14A 
compensate for the loss of cCdc14B.
Avian cells lacking cCdc14A and cCdc14B 
have a functional DNA damage checkpoint
Recently, it was suggested that hCdc14B is an essential compo-
nent of the G2 DNA damage checkpoint. In response to geno-
toxic stress in G2, hCdc14B relocalizes from the nucleolus to 
the nucleus and activates APC/C
Cdh1, leading to degradation of 
Plk1 and stabilization of claspin. This allows for efficient phos-
phorylation of the checkpoint kinase Chk1 and checkpoint 633 Cdc14-deficient cells have impaired DNA repair • Mocciaro et al.
Figure 1.  Functional G2 damage checkpoint in DT40 cells deleted for cCdc14A, cCdc14B, or Cdh1. (A) Flow cytometry analysis of the indicated cell lines 
incubated with Noco for 8 h with or without prior IR (IR + Noco and Noco). Cells were stained with PI and for pH3 to measure the MI. Values normalized 
to the MI of the corresponding Noco-treated cultures (n = 3). (B) Synchrony in G2 at the time of IR. (C) Cells synchronized in G2 were exposed to IR. Cells 
were harvested, and MI was measured by flow cytometry (n = 3). (D) Cells were irradiated, fixed (12 h after treatment), and stained for -tubulin (green) 
and centrin (red). The number of cells with more than two centrosomes was scored. Bar, 5 µm. (E) Quantification of phenotype in D (n = 3; 100 cells per 
each cell line) is shown. (F, top) WT, cCdc14A-KO, and cCdc14B-KO cells were analyzed by IB. (bottom) Quantification of Chk1(S345ph) before (t = 0) 
and after IR. Chk1(S345ph) was normalized to Chk1. Chk1(S345ph) in the untreated WT sample was set to 1 (n = 2). Error bars indicate mean ± SD.JCB • VOLUME 189 • NUMBER 4 • 2010   634
Figure 2.  Defective DNA repair in DT40 cCdc14A-KO and cCdc14B-KO cells. (A) The indicated cell lines were harvested either before (t = 0 h) or 
after IR, fixed, stained with PI and anti–-H2A.X, and analyzed by flow cytometry. (B) Quantification of the -H2A.X–positive cells in A (n = 3) is shown. 
(C) IB analysis of cCdc14A in cCdc14A-Res cells compared with WT. (D) WT, cCdc14A-KO, and cCdc14B-KO cells harvested either before (IR 0 h) or 
0.5 and 3 h after IR. Cells were fixed, stained for pH3 (red) and -H2A.X (green), and examined by fluorescence microscopy. Mitotic cells before and 
after IR. Anti–-H2A.X staining of the centrosome (arrowheads) was seen in some unirradiated cells. Bar, 5 µm. (E, left) The proportion of cells positive for 
pH3 and -H2A.X was scored as a percentage of total mitotic cells (n = 3; 100 mitotic cells per genotype). (right) The number of -H2A.X foci/cell was 
counted in projected and deconvolved images of mitotic cells positive for -H2A.X (n = 3; 20 mitotic cells). (F) The indicated cell lines were treated ± 1.5 µM 
DXR for 2 h and analyzed by single-cell gel electrophoresis (comet assay). Representative images are shown. Bar, 5 µm. (G) Tail moments for each time 
(n = 75; mean of two independent experiments) were quantified with ImageJ software. (H) Cell viability after IR analyzed by MTT assay (n = 3; P < 0.02). 
Error bars indicate mean ± SD.635 Cdc14-deficient cells have impaired DNA repair • Mocciaro et al.
cells  (Fig.  1 F) might be related to the presence of damaged 
DNA, we used flow cytometry to estimate the fraction of cells 
bearing phosphorylated histone 2A.X (-H2A.X), a DNA damage 
marker (Furuta et al., 2003), before and after IR. The proportion 
of -H2A.X–positive WT cells decreased from nearly 100% 
to 35% 3 h after IR, whereas 80% of cCdc14A-KO or 
cCdc14B-KO cells remained positive for -H2A.X at this time 
(Fig. 2, A and B). To confirm that this phenotype was caused 
by inactivation of cCdc14A or cCdc14B, we stably reintroduced 
cCdc14A or cCdc14B  cDNA  into  the  parental  nullizygous 
cells (cCdc14A-Res and cCdc14B-Res, respectively). cCdc14A-
Res cells expressed cCdc14A at close to WT levels (Fig. 2 C). 
Importantly, cCdc14A-Res and cCdc14B-Res cells were es-
sentially indistinguishable from WT in the kinetics of -H2A.X 
signal disappearance (Fig. 2, A and B).
To further investigate the kinetics of IR-induced DSB 
repair in WT and cCdc14-KO cells, we assessed the presence 
of -H2A.X foci by immunofluorescence (IF). In accordance 
with the flow cytometry analysis, 3 h after IR, 80% of the 
mitotic cCdc14A-KO cells and 50% of the mitotic cCdc14B-
KO cells still showed multiple -H2A.X foci. Strikingly, a sig-
nificant number of mitotic cells in unirradiated cCdc14A-KO 
or cCdc14B-KO cultures also contained -H2A.X foci (Fig. 2,   
D and E). It is most likely that the DSBs in untreated cells   
arise from failure to repair damage occurring spontaneously   
during the cell cycle. This raises the question of how cCdc14A-
KO and cCdc14B-KO cells with a functional G2 DNA dam-
age checkpoint are able to enter mitosis with DNA lesions. 
In yeast, the G2 checkpoint is sensitive to a single DSB (Bennett   
et al., 1997), whereas higher eukaryotes have a different sensi-
tivity threshold (Löbrich and Jeggo, 2007), which, for mam-
malian fibroblasts, was calculated to be 20 DSBs per cell 
(Deckbar et al., 2007). Indeed, 80% of untreated cCdc14A-
KO or cCdc14B-KO mitotic cells had <20 -H2A.X foci/cell 
(Fig. 2 E), thus explaining progression of cells bearing DNA 
damage into mitosis.
Bourke et al., 2007, 2010). Cells were exposed to IR and, after 
12 h, fixed and stained for -tubulin and centrin. As shown in 
Fig. 1 (D and E), WT, cCdc14A-KO, and cCdc14B-KO cells 
showed a 7–10-fold increase in interphase cells with more than 
two centrosomes after IR than in untreated cells. As expected 
(Bourke et al., 2010), Chk1-KO cells did not show a significant 
centrosome amplification after IR (Fig. 1, D and E). Collectively, 
these data indicate that DT40 cells lacking cCdc14A or cCdc14B 
have a fully functional G2 DNA damage checkpoint.
Key effectors of the G2 checkpoint 
are activated in response to damage in 
cCdc14A-KO and cCdc14B-KO cells
Protein extracts from cCdc14A-KO, cCdc14B-KO, and WT DT40 
cells were analyzed by immunoblotting (IB) for the presence of 
checkpoint-specific markers. Chk2 activation can be monitored 
via a slower migrating, hyperphosphorylated isoform (Zachos 
et al., 2003). After IR, DT40 WT, cCdc14A-KO, and cCdc14B-
KO showed Chk2 activation (Fig. 1 F, top), indicating that 
this aspect of the checkpoint is functional.
We next tested activation of Chk1 using an antibody against 
phosphorylated Chk1(S345ph) (Zachos et al., 2003). In DT40 
cells, phospho-Chk1 was hardly detectable before IR, followed 
by a peak 0.5 h after induction of DNA damage and decreased 
while DNA repair proceeded (Fig. 1 F, lanes 1–4). In contrast, 
in  cCdc14A-KO  and  cCdc14B-KO  cells,  the  basal  level  of 
Chk1(S345ph) was already slightly elevated before IR (Fig. 1 F,   
lane 5 vs. lane 1), and this persisted even 3 h after IR (Fig. 1 F, 
lanes 8 and 12). This suggests that spontaneous DNA damage 
may already be present in untreated cCdc14-KO cells and that 
induced DNA damage persists for longer than in WT cells.
cCdc14A-KO and cCdc14B-KO cells exhibit 
impaired DNA repair
To test the possibility that the higher basal level and persistence 
of Chk1 phosphorylation in cCdc14A-KO or cCdc14B-KO 
Figure 3.  Characterization of hCdc14A-defi-
cient cells. (A) Generation of a conditional-null 
hCdc14A cell line. (B) Southern blot analysis 
confirms  biallelic  mutations  of  the  hCdc14A 
locus in hTERT-RPE cells. WT (+/+), flox, neo, 
and  alleles are marked. (C) RT-PCR analy-
sis confirming expression of WT (arrowhead) 
and exon 2–deleted (asterisks) hCdc14A tran-
scripts.  (D)  MI  of  asynchronous  populations 
of Cdc14A
flox/+ and Cdc14A
/neo cells. Cells 
were fixed and stained with Hoechst (n = 3; 
300 cells per genotype). (E) Cdc14A
flox/+ and 
Cdc14A
/neo  cells  were  treated  with  Noco 
for 12 h followed by shake off into medium 
without Noco, fixation, and Hoechst (n = 3; 
300 cells per time point). (F) Cells were fixed, 
stained for -tubulin, and categorized by cen-
trosome number (n = 3; 200 cells per geno-
type). Error bars indicate mean ± SD.JCB • VOLUME 189 • NUMBER 4 • 2010   636
Consistent with the -H2A.X data (Fig. 2, A–E), untreated 
cCdc14A-KO and cCdc14B-KO cells exhibited longer comet 
tails  compared  with  WT  (Fig.  2  F).  Treatment  with  DXR   
To measure DNA damage directly, we used the comet 
assay (Fairbairn et al., 1995) in which DSBs confer increased 
electrophoretic mobility to DNA released from single cells. 
Figure 4.  Proficiency of G2 DNA damage checkpoint in hCdc14A
/neo or hCdc14B
/ cells. (A and B) Cells were treated for 6 (hTERT-RPE) or 4 h (HCT116) 
with Noco with or without prior IR. Fixed cells were stained with PI and pH3 (n = 3; MI of irradiated cells normalized to corresponding unirradiated cells). 
(C, top) Cdc14A
flox/+ and Cdc14A
/neo cells were treated with thymidine for 24 h and released for 7 h to reach G2 followed by treatment with or without 
DXR for 1 h. At the indicated times after release, cells were fixed and stained with PI and pH3. Flow cytometry is shown (n = 3). (bottom) Synchrony in G2 
at time of DXR treatment. (D, top) Cdc14B
flox/flox and Cdc14B
/ cells were synchronized in G1/S by double-thymidine block and released for 7 h and then 
as in C (n = 3). (bottom) Synchrony in G2 at the time of DXR treatment. (E, top) Cdc14A
flox/+ and Cdc14A
/neo cells were treated as in C, harvested, and 
analyzed by IB. (bottom) Levels of Cdk1(Y15ph) induction quantified as in Fig. 1 F. Anti-Cdk1 signals used for the normalization. (F, top) Cdc14B
flox/flox and 
Cdc14B
/ cells as in D. (bottom) Levels of Cdk1(Y15ph) as in E. Error bars indicate mean ± SD.637 Cdc14-deficient cells have impaired DNA repair • Mocciaro et al.
demonstrate that hCdc14A is dispensable for viability and 
proliferation of an untransformed human cell line.
Human cells deficient for hCdc14A or 
hCdc14B have a functional G2 DNA 
damage checkpoint
We  used  Cdc14A
/neo  cells  together  with  an  hCdc14B
/ 
HCT116 cell line (Berdougo et al., 2008) to investigate whether 
hCdc14A and hCdc14B are required for G2 DNA damage 
checkpoint proficiency. Asynchronously growing Cdc14A
flox/+ 
and Cdc14A
/neo cells were treated with Noco for 6 h with or   
without prior IR. Quantification of MI revealed that Cdc14A
/neo 
cells arrested in G2 as efficiently as controls (Fig. 4 A). Efficient 
arrest also occurred after DXR treatment (unpublished data). 
Cdc14B
/ cells were similarly DNA damage checkpoint pro-
ficient (Fig. 4 B). Nearly identical results were obtained when 
cells were exposed to DNA damage after synchronization in G2 
(Fig. 4, C and D).
We also monitored several markers of the DNA damage 
checkpoint in human cells by IB. Cdc14A
/neo and Cdc14B
/ 
cells synchronized in G2 activate the main effectors of the DNA 
damage checkpoint, as indicated by the increased phosphoryla-
tion of Chk1 on Ser345 after treatment with DXR (Fig. 4, E and F, 
lanes 12–14 vs. lanes 8–11). Moreover, inhibitory phosphorylation 
of Cdk1 on Tyr15 decreased in untreated Cdc14A
/neo and 
increased tails in all cell types (Fig. 2 F, t = 0). Strikingly, 3 h 
after treatment, DNA repair was essentially complete in WT 
cells, as indicated by the reduction in comet tails to control 
levels, whereas comet tails in cCdc14A-KO and cCdc14B-KO 
cells remained elevated. Based on the comet tail moment 
value,  which  quantitatively  represents  the  extent  of  DNA 
damage (Helma and Uhl, 2000), we estimate four- to fivefold 
higher damage in cCdc14A-deficient cells than in control cells 
3  h  after  DXR  treatment  (Fig.  2  G).  Thus,  cCdc14A-KO   
and cCdc14B-KO cells repair DSBs slower than WT cells. 
Consistent with the aforementioned observations, cells lack-
ing cCdc14A or cCdc14B had reduced survival rates after   
IR  compared  with  WT,  cCdc14A-Res,  and  cCdc14B-Res   
cells (Fig. 2 H).
Homozygous deletion of the Cdc14A locus 
in human cells
To  investigate  the  evolutionary  conservation  of  the  role  of 
hCdc14A  in  the  DNA  damage  responses,  we  generated  a 
Cdc14A
/neo cell line by disrupting both copies of Cdc14A in 
human telomerase reverse transcription (hTERT)–immortalized 
retinal pigment epithelial (RPE) cells (hTERT-RPE; Fig. 3, 
A–C). Cdc14A
/neo cultures did not show any significant alter-
ation in their MI (Fig. 3 D), in their ability to exit from mitosis 
(Fig. 3 E), or in centrosome number (Fig. 3 F). These findings 
Figure  5.  Defective  DNA  repair  in 
hCdc14A
/neo or hCdc14B
/ cells. (A and B)   
The  indicated  cell  lines  were  fixed  and 
stained for pH3 (red) and -H2A.X (green) 
and examined by microscopy. Mitotic cells 
are shown. Bars, 10 µm. (C and D) Quanti-
fication of the -H2A.X staining in A and B   
(n  =  3;  100  mitotic  cells  per  genotype).   
(E) Quantification of -H2A.X foci in mitotic 
cells (n = 3; 20 mitotic cells per genotype) as 
in Fig. 2 E. (F and G) Cell viability analyzed 
by MTT assay 48 h after treatment with IR   
(n = 3). Cells lacking hCdc14A or hCdc14B 
are significantly more sensitive than control 
cells (P < 0.02 and P < 0.01, respectively). 
Error bars indicate mean ± SD.JCB • VOLUME 189 • NUMBER 4 • 2010   638
expressing cCdc14A at close to endogenous levels were electroporated 
with the targeting vector as described previously (Saribasak and Arakawa, 
2006) and selected in 30 µg/ml blasticidin to obtain a nullizygous clone. 
To generate the cCdc14A rescue cell line, cCdc14A-KO cells were trans-
fected with the cCdc14A vector and selected in 0.5 µg/ml puromycin. 
Drug-resistant clones were screened for cCdc14A expression by IB, and 
a cell line with nearly endogenous levels of cCdc14A was identified and 
designated cCdc14A-Res.
For cCdc14B, a targeting vector containing a 3.3-kb left and 4.8-kb 
right arm of homology was synthesized by long-range PCR and cloned into 
Bluescript flanking a blasticidin selection cassette (Sonoda et al., 1998). To 
generate cCdc14B-deficient DT40 clones, DT40-Cre-ER cells expressing 
cCdc14B-HA were transfected with the targeting construct, using initially 
PCR and subsequently Southern blotting to genotype drug-resistant clones 
after  selection  in  30  µg/ml  blasticidin  (InvivoGen).  To  generate  the 
cCdc14B rescue cell line, cCdc14B-KO cells were transfected with a res-
cue vector containing the HA-tagged cCdc14B cDNA under control of the 
chicken -actin promoter and a puromycin-resistant cassette and selected 
in 0.5 µg/ml puromycin. Drug-resistant clones were screened for cCdc14B-
HA expression by IB, and the positive clones designated cCdc14B-Res.
Generation of hCdc14A-KO cells
To generate a conditional KO of the hCdc14A locus, 5 and 3 homology 
arms were amplified from a human BAC clone (RP11-976L7) and cloned 
into a vector containing a central FRT-neo-FRT-loxP cassette. A secondary 
loxP site was introduced downstream of exon 2 via QuikChange mutagen-
esis. The entire Cdc14A insert was subcloned into pAAV. Transfection of 
HEK293 cells, isolation of AAV particles, and infection of hTERT-RPE cells 
were performed as described previously (Berdougo et al., 2009). G418-
resistant colonies were screened by PCR. The neo cassette was excised 
from Cdc14A
flox-neo/+ cells by transfection with pCAAGS-FLPe followed by 
puromycin selection and limiting dilution. Individual colonies were tested 
for neo excision by genomic PCR and reacquisition of G418 sensitivity. 
Targeting of the second allele was achieved with a Cdc14A vector lack-
ing exon 2 (pAAV-Cdc14A). Cdc14A
flox/neo cells were converted to 
Cdc14A
/neo cells by infection with a recombinant adenovirus-expressing 
Cre recombinase. Targeted clones were confirmed by Southern blotting. 
The transcript from the exon 2–deleted hCdc14A gene contains a frame-
shift and does not code for a functional hCdc14A protein.
Cell culture and treatments
DT40 B-lymphoma cells DT40 B-lymphoma cells were grown in DME (Invit-
rogen) containing 10% FBS, 1% chicken serum, 1% glutamine, 1% sodium 
pyruvate, 10
5 M -mercaptoethanol, penicillin, and streptomycin at 40°C. 
HCT116 cells were grown in McCoy’s 5A medium (Invitrogen) supplemented 
with 10% FBS (Invitrogen) at 37°C. hTERT-RPE1 cell lines were grown in 
DME/F-12 medium supplemented with 10% FBS, 1% glutamine, and 
0.348% sodium bicarbonate at 37°C.
Cells were irradiated with 10 Gy IR using a caesium source (Gamma 
Cell 1000; Atomi Energy of Canada Ltd) and treated with 0.5 µg/ml Noco 
(Sigma-Aldrich), 5 µM aphidicolin (Sigma-Aldrich), 2 mM thymidine (Sigma-
Aldrich), 5 mM caffeine (Sigma-Aldrich), 1.5 µM DXR (Applichem), and 
0.1 mM 4-hydroxytamoxifen (Sigma-Aldrich) as appropriate.
Flow cytometry
Cells were fixed in 70% ethanol in PBS overnight. For DNA content anal-
ysis, cells were pelleted and resuspended in PBS containing 1 mg/ml 
RNase (Sigma-Aldrich) and 10 mg/ml propidium iodide (PI) incubated   
at room temperature for 30 min then analyzed using a flow cytometer 
(FACScan; BD).
For MI determinations, fixed cells were incubated with polyclonal 
anti–phospho histone H3 antibodies followed by FITC-conjugated second-
ary antibody (Invitrogen). Cells were counterstained with propidium iodide 
and analyzed for FITC fluorescence and DNA content by flow cytometry.
For determination of -H2A.X foci, fixed cells were incubated with 
monoclonal anti–-H2A.X antibody followed by FITC-conjugated second-
ary antibody and counterstained with propidium iodide.
IB
Cell extracts were prepared in RIPA buffer (150 mM NaCl, 1% NP-40, 
0.5% Na deoxycholate, 0.1% SDS, 50 mM Tris-Cl, pH 8.0, 1 mM PMSF, 
complete protease inhibitor cocktail [Roche], and PhosStop phosphatase 
inhibitor cocktail [Roche]), resolved by SDS-PAGE, and blotted onto nitro-
cellulose membranes (GE Healthcare). Antibodies against Chk1(S345ph) 
(Cell Signaling Technology), Chk1 (G-4; Santa Cruz Biotechnology, Inc.), 
Cdk1(Y15ph) (IL-15; Santa Cruz Biotechnology, Inc.), and Cdk1 (cl 17; 
Cdc14B
/ cells after release from synchronization in G2, whereas 
it persisted at high levels after damage (Fig. 4, E and F, lanes 9–11 
vs. lanes 12–14), indicating an arrest in G2. Interestingly, as in 
cCdc14A-KO DT40 cells, the basal level of Chk1 phosphoryla-
tion was already elevated in unirradiated Cdc14A
/neo cells com-
pared with Cdc14A
flox/+ cells (Fig. 4 E, lanes 1–4 vs. lanes 8–11).
These  findings  prompted  us  to  investigate  whether 
Cdc14A
/neo or Cdc14B
/ cells also showed an increased 
number of mitotic cells bearing DNA damage foci in the absence 
of DSB-inducing treatments (Fig. 5, A and B). The percent-
age of mitotic cells exhibiting -H2A.X foci was significantly 
higher in Cdc14A
/neo and Cdc14B
/ cultures compared with 
controls (Fig. 5, C and D). Also, in human cells, the number of 
foci was usually <20 per cell (Fig. 5 E), explaining progression 
of these cells into mitosis. These results suggest that in human 
cells, Cdc14A and Cdc14B are also likely to be required for 
efficient DNA repair. The persistence of DNA damage foci in   
Cdc14A
/neo and Cdc14B
/ cells was associated with lower 
survival rates than controls after IR (Fig. 5, F and G), indicating 
a higher sensitivity of these mutants to DNA damage.
Conclusions
In this study, we evaluate the functions of avian and human 
Cdc14A and Cdc14B in cells lacking these gene products. Sur-
prisingly, Cdc14A-KO and Cdc14B-KO cells are viable and do 
not show severe cellular defects. With respect to Cdc14B, our 
findings contrast with the G2 checkpoint defect previously 
reported  in  human  cells  depleted  for  Cdc14B  using  siRNA 
(Bassermann et al., 2008). This is unlikely to be caused by cell 
type specificity because both avian lymphocytes and human 
epithelial cells genetically deleted for Cdc14B retained normal 
G2 checkpoint proficiency. It seems more likely that the effects 
of complete and permanent loss of Cdc14B function somehow 
differ from the more short-term and typically less-complete 
ablation achieved through siRNA depletion.
Although Cdc14A-KO or Cdc14B-KO cells are DNA 
damage  checkpoint  proficient,  their  capacity  to  repair  DNA 
is diminished, resulting in the presence of a higher number of   
-H2A.X foci compared with controls. This is true even without 
any treatment with DNA damage–inducing agents and results 
in an increased sensitivity of the Cdc14-KOs to IR. Thus, these 
data uncover a new requirement for avian and human Cdc14A 
and Cdc14B in DNA repair.
Materials and methods
Generation of cCdc14A-KO and cCdc14B-KO cells
cCdc14A and cCdc14B cDNAs were isolated by RT-PCR using total RNA 
extracted from DT40 WT cells as template. For cCdc14A, two separate 
targeting vectors containing a 2.3-kb left and 3-kb right arm of homology 
were synthesized and cloned into Bluescript (Agilent Technologies) flanking 
either puromycin or blasticidin selection cassettes (Sonoda et al., 1998). 
After one round of targeting with the puromycin-targeting vector, drug-
resistant clones were genotyped by PCR to identify cCdc14A
+/ cells. After 
excision of the puromycin cassette by induction of Cre recombinase, one 
hemizygous clone was electroporated with a rescue vector containing the 
HA-tagged cCdc14A cDNA under control of the chicken -actin promoter 
and a puromycin-resistant cassette (plasmid derived from pBluescript; pro-
vided by J.M. Buerstedde, Institute for Molecular Radiobiology, Munich, 
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Santa Cruz Biotechnology, Inc.) were used for IB. A polyclonal rabbit anti-
serum specific for avian cCdc14A was generated against the C-terminal 
257 amino acids of the protein. The antibody against Chk2 was described 
previously (Zachos et al., 2003). Blots were scanned using a luminescence 
fluorimager (LAS4000; Fujifilm) and quantified using Multi Gauge soft-
ware (Fujifilm).
IF and microscopy
Antibodies  against  -tubulin  (GTU-88;  Sigma-Aldrich),  cCdc14A,  GFP 
(purified  in  house),  fibrillarin  (4G9-E4;  Cytoskeleton,  Inc.),  B23  (C-19; 
Santa Cruz Biotechnology, Inc.), -H2A.X(S139) (Millipore), and pH3(S10) 
(Millipore) were used for IF. In brief, cells were either grown on coverslips 
or allowed to attach to polylysine slides (VWR International), fixed with 
4%  paraformaldehyde  for  10  min  at  37°C,  permeabilized  with  PBS-T   
(PBS + 0.1% Triton X-100), and blocked with 10% FBS in PBS-T for 30 min 
at 37°C before application of primary antibody. Alternatively, cells were 
fixed in 100% methanol at 20°C for 5 min. Alexa Fluor 488– and 594–
conjugated secondary antibodies (Invitrogen) were used. For the detec-
tion of -H2A.X foci, cells were fixed with 3.7% formaldehyde in PBS for   
15 min, permeabilized with 0.1% Triton X-100 in PBS for 10 min, and 
blocked with 10% fetal calf serum and 0.5% bovine serum albumin in 
PBS for 30 min. Anti-pH3 and –-H2A.X were diluted 1:100 in blocking 
buffer. Cells were incubated with the antibodies for 60 min and washed 
three times for 5 min in blocking buffer. Anti–rabbit Alexa Fluor 594 and 
anti–mouse Alexa Fluor 488 (Invitrogen) were each used at 1:500 dilution 
in blocking buffer. Cells were incubated with the secondary antibodies for 
60 min, washed twice for 5 min with blocking buffer, and once for 5 min 
with PBS before being mounted in ProLong gold (Invitrogen).
Images were taken on a microscope (DeltaVision RT; Applied Preci-
sion) equipped with GFP and TRITC filters (Chroma Technology Corp.), 
a Plan Apo 100× NA 1.4 oil immersion objective (IX70; Olympus), soft-
WoRx software (Applied Precision), and a camera (CoolSNAP HQ; Photo-
metrics). Image stacks were deconvolved and projected using softWoRx.
Single-cell gel electrophoresis (alkaline comet) assay
Single-cell comet assays were performed as per the manufacturer’s instruc-
tions (Trevigen). Nuclei were visualized using epifluorescent illumination 
on a microscope (Carl Zeiss, Inc.), and images were analyzed using   
ImageJ software (National Institutes of Health).
Cell viability assay
Treated or untreated cells were seeded in octuplicate microtiter wells at   
5 × 10
3 cells/well for hTERT-RPE1 and HCT116 or at 10
5 cells/well for 
DT40, incubated overnight, and irradiated or grown in medium for 48 h 
or 24 h, respectively. Viability was measured by method of transcriptional 
and translational (MTT) assay. Results were expressed as the OD550 relative 
to that of untreated cells.
Online supplemental material
Fig. S1 shows localization of cCdc14A and cCdc14B, cCdc14A-KO strat-
egy, and confirmation of KO. Fig. S2 shows cCdc14B-KO strategy, confir-
mation of cCdc14B-KO cells, and absence of growth defects in cCdc14B-KO 
cells. Fig. S3 shows localization of cCdc14A and cCdc14B after IR and 
absence  of  adaptation.  Online  supplemental  material  is  available  at 
http://www.jcb.org/cgi/content/full/jcb.200910057/DC1.
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